ZM001
/ Beijing Imunopharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 28, 2025
Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus Erythematosus
(clinicaltrials.gov)
- P1 | N=18 | Not yet recruiting | Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd.
New P1 trial • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
1 to 1
Of
1
Go to page
1